Key result
Left ventricular non-compaction myocardium syndrome is a genetically heterogeneous condition that currently lacks unified diagnostic criteria and standardized treatment guidelines.
This review highlights the current understanding and gaps in knowledge regarding left ventricle non-compaction myocardium, emphasizing the need for unified diagnostic criteria and management guidelines.
LV non-compaction diagnosis warrants caution amid inconsistent criteria; leaves open standardization of guidelines through prospective research.
The left ventricle non-compaction myocardium syndrome is relatively new diagnosis entered clinical practice with improvement of the heart visualization methods. There is plenty of studies on genetic heterogeneity of non-compaction myocardium syndrome and its impact on a variety of associated cardiomyopathies. However, there is no single opinion on pathogenesis of non-compaction, as there are no unified diagnostic criteria and no guideline on treatment and management of patients with this syndrome. Current review provides a summary of data on this pathology nature, its genetics, diagnostics and treatment.
No takes yet. Share an insight, caveat, or question.
Polyak et al. (2017) conducted a review in Left ventricular non-compaction myocardium syndrome. Left ventricular non-compaction myocardium syndrome was evaluated. Left ventricular non-compaction myocardium syndrome is a genetically heterogeneous condition that currently lacks unified diagnostic criteria and standardized treatment guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: